{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:27:51Z","timestamp":1793395671233,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,1,27]],"date-time":"2012-01-27T00:00:00Z","timestamp":1327622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00467-011-2092-6","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T09:37:31Z","timestamp":1327570651000},"page":"2031-2038","source":"Crossref","is-referenced-by-count":78,"title":["Cystinuria: mechanisms and management"],"prefix":"10.1007","volume":"27","author":[{"given":"Donna J.","family":"Claes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,27]]},"reference":[{"key":"2092_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-004-1663-1","volume":"20","author":"T Knoll","year":"2005","unstructured":"Knoll T, Zollner A, Wendt-Nordahl G, Michel MS, Alken P (2005) Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol 20:19\u201324","journal-title":"Pediatr Nephrol"},{"key":"2092_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.semnephrol.2008.01.011","volume":"28","author":"A Mattoo","year":"2008","unstructured":"Mattoo A, Goldfarb DS (2008) Cystinuria. Semin Nephrol 28:181\u2013191","journal-title":"Semin Nephrol"},{"key":"2092_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ucl.2007.04.006","volume":"34","author":"A Rogers","year":"2007","unstructured":"Rogers A, Kalakish S, Desai RA, Assimos DG (2007) Management of cystinuria. Urol Clin North Am 34:347\u2013362","journal-title":"Urol Clin North Am"},{"key":"2092_CR4","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1159\/000080255","volume":"98","author":"P Goodyer","year":"2004","unstructured":"Goodyer P (2004) The molecular basis of cystinuria. Nephron Exp Nephrol 98:e45\u2013e49","journal-title":"Nephron Exp Nephrol"},{"key":"2092_CR5","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/01.ASN.0000029586.17680.E5","volume":"13","author":"L Dello Strologo","year":"2002","unstructured":"Dello Strologo L, Pras E, Pontesilli C, Beccia E, Ricci-Barbini V, de Sanctis L, Ponzone A, Gallucci M, Bisceglia L, Zelante L, Jimenez-Vidal M, Font M, Zorzano A, Rousaud F, Nunes V, Gasparini P, Palacin M, Rizzoni G (2002) Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 13:2547\u20132553","journal-title":"J Am Soc Nephrol"},{"key":"2092_CR6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1464-410X.2006.06169.x","volume":"97","author":"EM Worcester","year":"2006","unstructured":"Worcester EM, Coe FL, Evan AP, Parks JH (2006) Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int 97:1285\u20131290","journal-title":"BJU Int"},{"key":"2092_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00240-010-0271-8","volume":"38","author":"FL Coe","year":"2010","unstructured":"Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38:147\u2013160","journal-title":"Urol Res"},{"key":"2092_CR8","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/sj.ki.5000268","volume":"69","author":"AP Evan","year":"2006","unstructured":"Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227\u20132235","journal-title":"Kidney Int"},{"key":"2092_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/09687680010028771","volume":"18","author":"M Palacin","year":"2001","unstructured":"Palacin M, Fernandez E, Chillaron J, Zorzano A (2001) The amino acid transport system b(o,+) and cystinuria. Mol Membr Biol 18:21\u201326","journal-title":"Mol Membr Biol"},{"key":"2092_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08035320600649473","volume":"95","author":"L Dello Strologo","year":"2006","unstructured":"Dello Strologo L, Rizzoni G (2006) Cystinuria. Acta Paediatr Suppl 95:31\u201333","journal-title":"Acta Paediatr Suppl"},{"key":"2092_CR11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.ki.5002790","volume":"73","author":"SM Camargo","year":"2008","unstructured":"Camargo SM, Bockenhauer D, Kleta R (2008) Aminoacidurias: clinical and molecular aspects. Kidney Int 73:918\u2013925","journal-title":"Kidney Int"},{"key":"2092_CR12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jmg.2004.022244","volume":"42","author":"M Font-Llitjos","year":"2005","unstructured":"Font-Llitjos M, Jimenez-Vidal M, Bisceglia L, Di Perna M, de Sanctis L, Rousaud F, Zelante L, Palacin M, Nunes V (2005) New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 42:58\u201368","journal-title":"J Med Genet"},{"key":"2092_CR13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jpurol.2005.11.011","volume":"2","author":"E Brauers","year":"2006","unstructured":"Brauers E, Hozyasz K, Golabek B, Slowik M, Schmidt C, Vester U, Zerres K, Eggermann T (2006) Identification of novel cystinuria mutations in pediatric patients. J Pediatr Urol 2:575\u2013578","journal-title":"J Pediatr Urol"},{"key":"2092_CR14","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1523-1755.2002.kid552.x","volume":"62","author":"E Botzenhart","year":"2002","unstructured":"Botzenhart E, Vester U, Schmidt C, Hesse A, Halber M, Wagner C, Lang F, Hoyer P, Zerres K, Eggermann T (2002) Cystinuria in children: distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes. Kidney Int 62:1136\u20131142","journal-title":"Kidney Int"},{"key":"2092_CR15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2174\/156652408785747997","volume":"8","author":"K Martens","year":"2008","unstructured":"Martens K, Jaeken J, Matthijs G, Creemers JW (2008) Multi-system disorder syndromes associated with cystinuria type I. Curr Mol Med 8:544\u2013550","journal-title":"Curr Mol Med"},{"key":"2092_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/MOU.0b013e328333b674","volume":"20","author":"HG Tiselius","year":"2010","unstructured":"Tiselius HG (2010) New horizons in the management of patients with cystinuria. Curr Opin Urol 20:169\u2013173","journal-title":"Curr Opin Urol"},{"key":"2092_CR17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0022-5347(05)67633-1","volume":"163","author":"F Barbey","year":"2000","unstructured":"Barbey F, Joly D, Rieu P, Mejean A, Daudon M, Jungers P (2000) Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163:1419\u20131423","journal-title":"J Urol"},{"key":"2092_CR18","volume-title":"Comprehensive pediatric nephrology","author":"DF Geary","year":"2008","unstructured":"Geary DF, Schaefer F (2008) Comprehensive pediatric nephrology. Mosby\/Elsevier, Philadelphia"},{"key":"2092_CR19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-5347(05)65461-4","volume":"167","author":"MC Martins","year":"2002","unstructured":"Martins MC, Meyers AA, Whalley NA, Rodgers AL (2002) Cystine: a promoter of the growth and aggregation of calcium oxalate crystals in normal undiluted human urine. J Urol 167:317\u2013321","journal-title":"J Urol"},{"key":"2092_CR20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.urology.2008.04.003","volume":"72","author":"SP Sterrett","year":"2008","unstructured":"Sterrett SP, Penniston KL, Wolf JS Jr, Nakada SY (2008) Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate. Urology 72:278\u2013281","journal-title":"Urology"},{"key":"2092_CR21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0002-9343(86)90722-9","volume":"80","author":"IA Jaffe","year":"1986","unstructured":"Jaffe IA (1986) Adverse effects profile of sulfhydryl compounds in man. Am J Med 80:471\u2013476","journal-title":"Am J Med"},{"key":"2092_CR22","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/0006-2952(81)90492-5","volume":"30","author":"PC Rumsby","year":"1981","unstructured":"Rumsby PC, Shepherd DM (1981) The effect of penicillamine on vitamin B6 function in man. Biochem Pharmacol 30:3051\u20133053","journal-title":"Biochem Pharmacol"},{"key":"2092_CR23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/oxfordjournals.jbchem.a130280","volume":"74","author":"I Tomono","year":"1973","unstructured":"Tomono I, Abe M, Matsuda M (1973) Effect of penicillamine (a vitamin B6 antagonist) on pyridoxal enzymes. J Biochem 74:587\u2013592","journal-title":"J Biochem"},{"key":"2092_CR24","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00467-007-0575-2","volume":"22","author":"L Dello Strologo","year":"2007","unstructured":"Dello Strologo L, Laurenzi C, Legato A, Pastore A (2007) Cystinuria in children and young adults: success of monitoring free-cystine urine levels. Pediatr Nephrol 22:1869\u20131873","journal-title":"Pediatr Nephrol"},{"key":"2092_CR25","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.juro.2008.08.057","volume":"180","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Coughlin CR II, Kaplan P (2008) Penicillamine therapy for pediatric cystinuria: experience from a cohort of American children. J Urol 180:2620\u20132623","journal-title":"J Urol"},{"key":"2092_CR26","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.1987.00370080045011","volume":"147","author":"JA Sloand","year":"1987","unstructured":"Sloand JA, Izzo JL Jr (1987) Captopril reduces urinary cystine excretion in cystinuria. Arch Intern Med 147:1409\u20131412","journal-title":"Arch Intern Med"},{"key":"2092_CR27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-5347(05)66044-2","volume":"166","author":"FL Coe","year":"2001","unstructured":"Coe FL, Clark C, Parks JH, Asplin JR (2001) Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs. J Urol 166:688\u2013693","journal-title":"J Urol"},{"key":"2092_CR28","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0022-5347(05)67011-5","volume":"164","author":"Y Nakagawa","year":"2000","unstructured":"Nakagawa Y, Asplin JR, Goldfarb DS, Parks JH, Coe FL (2000) Clinical use of cystine supersaturation measurements. J Urol 164:1481\u20131485","journal-title":"J Urol"},{"key":"2092_CR29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(05)64037-2","volume":"169","author":"PK Pietrow","year":"2003","unstructured":"Pietrow PK, Auge BK, Weizer AZ, Delvecchio FC, Silverstein AD, Mathias B, Albala DM, Preminger GM (2003) Durability of the medical management of cystinuria. J Urol 169:68\u201370","journal-title":"J Urol"},{"key":"2092_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-5347(05)64824-0","volume":"168","author":"DG Assimos","year":"2002","unstructured":"Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168:27\u201330","journal-title":"J Urol"},{"key":"2092_CR31","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.juro.2009.04.084","volume":"182","author":"EH Landau","year":"2009","unstructured":"Landau EH, Shenfeld OZ, Pode D, Shapiro A, Meretyk S, Katz G, Katz R, Duvdevani M, Hardak B, Cipele H, Hidas G, Yutkin V, Gofrit ON (2009) Extracorporeal shock wave lithotripsy in prepubertal children: 22-year experience at a single institution with a single lithotriptor. J Urol 182:1835\u20131839","journal-title":"J Urol"},{"key":"2092_CR32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000112603","volume":"80","author":"K Ahmed","year":"2008","unstructured":"Ahmed K, Khan MS, Thomas K, Challacombe B, Bultitude M, Glass J, Tiptaft R, Dasgupta P (2008) Management of cystinuric patients: an observational, retrospective, single-centre analysis. Urol Int 80:141\u2013144","journal-title":"Urol Int"},{"key":"2092_CR33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00240-007-0117-1","volume":"35","author":"SC Kim","year":"2007","unstructured":"Kim SC, Burns EK, Lingeman JE, Paterson RF, McAteer JA, Williams JC Jr (2007) Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy. Urol Res 35:319\u2013324","journal-title":"Urol Res"},{"key":"2092_CR34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.2215\/CJN.05811108","volume":"4","author":"AD Rule","year":"2009","unstructured":"Rule AD, Bergstralh EJ, Melton LJ III, Li X, Weaver AL, Lieske JC (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4:804\u2013811","journal-title":"Clin J Am Soc Nephrol"},{"key":"2092_CR35","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2215\/CJN.10651110","volume":"6","author":"AD Rule","year":"2011","unstructured":"Rule AD, Krambeck AE, Lieske JC (2011) Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6:2069\u20132075","journal-title":"Clin J Am Soc Nephrol"},{"key":"2092_CR36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00240-007-0127-z","volume":"36","author":"G Wendt-Nordahl","year":"2008","unstructured":"Wendt-Nordahl G, Sagi S, Bolenz C, Alken P, Michel MS, Knoll T (2008) Evaluation of cystine transport in cultured human kidney cells and establishment of cystinuria type I phenotype by antisense technology. Urol Res 36:25\u201329","journal-title":"Urol Res"},{"key":"2092_CR37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1191968","volume":"330","author":"JD Rimer","year":"2010","unstructured":"Rimer JD, An Z, Zhu Z, Lee MH, Goldfarb DS, Wesson JA, Ward MD (2010) Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design. Science 330:337\u2013341","journal-title":"Science"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-2092-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-011-2092-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-011-2092-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:03:47Z","timestamp":1559091827000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-011-2092-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,27]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2092"],"URL":"https:\/\/doi.org\/10.1007\/s00467-011-2092-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,27]]}}}